Search Results - Seagle, B.L

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Single-gene prognostic biomarkers in ovarian cancer: Vetting associations by survival-determining clinical confounders

    Single-gene prognostic biomarkers in ovarian cancer: Vetting associations by survival-determining clinical confounders by Seagle, B.L, Strohl, A.E, Nieves, W, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Vaginal brachytherapy and multi-agent chemotherapy increases survival of women with stage I carcinosarcoma

    Vaginal brachytherapy and multi-agent chemotherapy increases survival of women with stage I carcinosarcoma by Kanis, M.J, Seagle, B.L, Kocherginsky, M, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Prognosis and survival of gynecologic leiomyosarcoma: A National Cancer Data Base study

    Prognosis and survival of gynecologic leiomyosarcoma: A National Cancer Data Base study by Seagle, B.L, Sobecki-Rausch, J, Strohl, A.E, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Ovarian Cancer Early Detection and Prevention Program (OCEDPP): A specimen and data study

    Ovarian Cancer Early Detection and Prevention Program (OCEDPP): A specimen and data study by Kanis, M.J, Hope, K, Seagle, B.L, Shulman, L, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Upregulated Wnt signaling is associated with increased survival of patients with high-grade serous ovarian cancer

    Upregulated Wnt signaling is associated with increased survival of patients with high-grade serous ovarian cancer by Dandapani, M, Seagle, B.L, Samuelson, R, Eng, K, Odunsi, K.O, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    High-grade serous ovarian cancer primary tumor BRCA1 mRNA expression is a candidate biomarker for patient selection for intraperitoneal chemotherapy

    High-grade serous ovarian cancer primary tumor BRCA1 mRNA expression is a candidate biomarker for patient selection for intraperitoneal chemotherapy by Seagle, B.L, Dandapani, M, Samuelson, R, Eng, K, Odunsi, K.O, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Exon-specific p53 mutations drive different models of ovarian cancer risk

    Exon-specific p53 mutations drive different models of ovarian cancer risk by Seagle, B.L, Eng, K, Odunsi, K.O, Shahabi, S

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Complications and costs of minimally invasive versus open radical hysterectomy for early stage cervical cancer

    Complications and costs of minimally invasive versus open radical hysterectomy for early stage cervical cancer by Margul, D., Zandi, R., Yang, J., Seagle, B.L., Alexander, A.L., Barber, E.L., Kocherginsky, M., Shahabi, S.

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: